Relmada Therapeutics Inc (RLMD)
3.66
-0.06
(-1.61%)
USD |
NASDAQ |
May 03, 16:00
3.66
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics 1 Year Total Returns (Daily): 40.38% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | 40.38% |
| May 01, 2024 | 35.66% |
| April 30, 2024 | 44.44% |
| April 29, 2024 | 40.08% |
| April 26, 2024 | 43.98% |
| April 25, 2024 | 47.41% |
| April 24, 2024 | 53.78% |
| April 23, 2024 | 48.11% |
| April 22, 2024 | 46.59% |
| April 19, 2024 | 42.35% |
| April 18, 2024 | 43.81% |
| April 17, 2024 | 52.44% |
| April 16, 2024 | 68.27% |
| April 15, 2024 | 64.21% |
| April 12, 2024 | 96.20% |
| April 11, 2024 | 92.56% |
| April 10, 2024 | 97.81% |
| April 09, 2024 | 112.4% |
| April 08, 2024 | 115.0% |
| April 05, 2024 | 106.8% |
| April 04, 2024 | 94.61% |
| April 03, 2024 | 98.73% |
| April 02, 2024 | 118.6% |
| April 01, 2024 | 115.9% |
| March 28, 2024 | 90.57% |
| Date | Value |
|---|---|
| March 27, 2024 | 93.67% |
| March 26, 2024 | 106.6% |
| March 25, 2024 | 115.9% |
| March 22, 2024 | 107.7% |
| March 21, 2024 | 92.56% |
| March 20, 2024 | 83.26% |
| March 19, 2024 | 117.4% |
| March 18, 2024 | 123.5% |
| March 15, 2024 | 111.7% |
| March 14, 2024 | 79.00% |
| March 13, 2024 | 102.2% |
| March 12, 2024 | 91.35% |
| March 11, 2024 | 99.65% |
| March 08, 2024 | 93.01% |
| March 07, 2024 | 93.62% |
| March 06, 2024 | 86.59% |
| March 05, 2024 | 77.53% |
| March 04, 2024 | 78.37% |
| March 01, 2024 | 102.4% |
| February 29, 2024 | 70.14% |
| February 28, 2024 | 70.56% |
| February 27, 2024 | 73.90% |
| February 26, 2024 | 78.01% |
| February 23, 2024 | 70.06% |
| February 22, 2024 | 61.75% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.56%
Minimum
Apr 05 2023
925.7%
Maximum
Dec 04 2019
82.36%
Average
-18.06%
Median
1 Year Total Returns (Daily) Benchmarks
| Cyclacel Pharmaceuticals Inc | -73.54% |
| Lifecore Biomedical Inc | 47.91% |
| Corvus Pharmaceuticals Inc | 67.96% |
| NeuroBo Pharmaceuticals Inc | -25.14% |
| Ensysce Biosciences Inc | -84.15% |